CoChat

Targeting mTOR Signaling Can Prevent the Progression of FSGS

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Mammalian target of rapamycin (mTOR) signaling is involved in a variety of kidney diseases. Clinical trials administering mTOR inhibitors to patients with FSGS, a prototypic podocyte disease, led to conflicting results, ranging from remission to deterioration of kidney function. Here, we combined complex genetic titration of mTOR complex 1 (mTORC1) levels in murine glomerular disease models, pharmacologic studies, and human studies to precisely delineate the role of mTOR in FSGS. mTORC1 target genes were significantly induced in microdissected glomeruli from both patients with FSGS and a murine FSGS model. Furthermore, a mouse model with constitutive mTORC1 activation closely recapitulated human FSGS. Notably, the complete knockout of mTORC1 by induced deletion of both Raptor alleles accelerated the progression of murine FSGS models. However, lowering mTORC1 signaling by deleting just one Raptor allele ameliorated the progression of glomerulosclerosis. Similarly, low-dose treatment with the mTORC1 inhibitor rapamycin efficiently diminished disease progression. Mechanistically, complete pharmacologic inhibition of mTOR in immortalized podocytes shifted the cellular energy metabolism toward reduced rates of oxidative phosphorylation and anaerobic glycolysis, which correlated with increased production of reactive oxygen species. Together, these data suggest that podocyte injury and loss is commonly followed by adaptive mTOR activation. Prolonged mTOR activation, however, results in a metabolic podocyte reprogramming leading to increased cellular stress and dedifferentiation, thus offering a treatment rationale for incomplete mTOR inhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2016050519

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 79

Metadata

Authors
Zschiedrich, S., Bork, T., Liang, W., Wanner, N., Eulenbruch, K., Munder, S., Hartleben, B., Kretz, O., Gerber, S., Simons, M., Viau, A., Burtin, M., Wei, C., Reiser, J., Herbach, N., Rastaldi, M.-P., Cohen, C. D., Tharaux, P.-L., Terzi, F., Walz, G., Gödel, M., & Huber, T. B.
Affiliations
  • University of Freiburg (DE)
  • Inserm (FR)
  • Rush University Medical Center (US)
  • Ludwig-Maximilians-Universität München (DE)
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
  • München Klinik (DE)
Corresponding author
  • Zschiedrich, Stefan
  • Bork, Tillmann
  • Liang, Wei
  • Wanner, Nicola
  • Eulenbruch, Kristina
  • Munder, Stefan
  • Hartleben, Björn
  • Kretz, Oliver
  • Viau, Amandine
  • Herbach, Nadja
  • Walz, Gerd
  • Gödel, Markus
  • Huber, Tobias B
Venue
Journal of the American Society of Nephrology
Published
2017-03-07
Volume
28
Issue
7
Pages
2144-2157
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W2594291574
Cited by
76
References
55
Citations by year
2026: 3 · 2025: 11 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 10 · 2019: 7 · 2018: 6 · 2017: 6
FWCI
7.10
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Deutsche Forschungsgemeinschaft (HU 1016/8‐1, CRC1140, 1016/8-1, 616891, GSC‐4, GSC-4/Spemann Graduate School, (EXC 294), CRC992)
  • Bundesministerium für Bildung und Forschung (616891, 01GM1518C, STOP-FSGS-01GM1518C)
  • Horizon 2020 Framework Programme (115974)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
mTOR signaling, mTORC1, focal segmental glomerulosclerosis, podocyte injury, raptors, rapamycin, oxidative phosphorylation, anaerobic glycolysis, reactive oxygen species, podocyte dedifferentiation
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Animals, Glomerulosclerosis, Focal Segmental, Humans, Immunosuppressive Agents, Signal Transduction, Disease Progression, Sirolimus, Multiprotein Complexes, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.